What did researchers learn from this trial?
This trial helped researchers learn more about how tremelimumab and
durvalumab affect people with advanced HCC.
Researchers look at the results of many trials to decide which treatments work
best and are safest. This summary shows only the main results from this one trial.
Other trials may provide new information or different results.
At the time this summary was made and approved by the sponsor, further clinical
trials with tremelimumab and durvalumab were ongoing.
19 | Clinical Trial Results